Haley David, Technology Insights
The 2013 Heart Rhythm Society (HRS) was full of innovation. From new technologies to impressive research, leading electrophysiologists worldwide gathered to share best practices on arrhythmia management and make strides towards understanding the mechanisms behind arrhythmias.
HRS 2013: Is the new cryoballoon the answer to our AF ablation woes?
With 2013 in full swing, we’ve taken a step back to review the major CV technology stories of 2012. From devices gaining FDA approval to therapies demonstrating paradigm-shifting potential, 2012 was a year of significant innovation across CV services. To help CV leaders nationwide distill the most impactful new research, data, and FDA approvals, we’ve broken down the four top stories of 2012 and what you need to know in 2013.
Top cardiovascular technology trends of 2012
It was an exciting summer in the EP world. With the Department of Justice’s (DOJ) release of its “Resolution Model” for the ongoing implantable cardioverter defibrillator (ICD) investigation and the FDA’s recommendation for additional imaging of Riata leads, cardiovascular (CV) programs nationwide have had many hoops to jump through and much paperwork to complete. Moreover, with Boston Scientific’s subcutaneous ICD (S-ICD) gaining FDA approval on Sept. 28, fall is looking similarly eventful for EP programs nationwide.
DOJ investigation, Riata leads, and S-ICD approval: A review of recent ICD news